Dipen J. Parekh

ORCID: 0000-0002-8261-5185
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Treatment and Research
  • Urological Disorders and Treatments
  • Renal cell carcinoma treatment
  • Urinary and Genital Oncology Studies
  • Renal and Vascular Pathologies
  • Urologic and reproductive health conditions
  • Urinary Bladder and Prostate Research
  • Pediatric Urology and Nephrology Studies
  • Renal and related cancers
  • Radiomics and Machine Learning in Medical Imaging
  • Ureteral procedures and complications
  • Genital Health and Disease
  • MRI in cancer diagnosis
  • Cancer, Hypoxia, and Metabolism
  • Molecular Biology Techniques and Applications
  • Cancer, Lipids, and Metabolism
  • Statistical Methods in Clinical Trials
  • Tissue Engineering and Regenerative Medicine
  • Organ Donation and Transplantation
  • Pelvic floor disorders treatments
  • Colorectal Cancer Screening and Detection
  • Cardiac, Anesthesia and Surgical Outcomes
  • Testicular diseases and treatments

Sylvester Comprehensive Cancer Center
2016-2025

University of Miami
2016-2025

University of Miami Health System
2021-2024

California State Polytechnic University
2024

Media Working Group
2021

Albert Einstein College of Medicine
2021

Urology San Antonio
2011-2020

Communities In Schools of Orange County
2020

Phoenix (United States)
2020

Columbus Oncology and Hematology Associates
2020

No AccessJournal of UrologyAdult Urology1 Feb 2013Perioperative Outcomes and Oncologic Efficacy from a Pilot Prospective Randomized Clinical Trial Open Versus Robotic Assisted Radical Cystectomy Dipen J. Parekh, Jamie Messer, John Fitzgerald, Barbara Ercole, Robert Svatek ParekhDipen Parekh , MesserJamie Messer FitzgeraldJohn Fitzgerald ErcoleBarbara Ercole SvatekRobert View All Author Informationhttps://doi.org/10.1016/j.juro.2012.09.077AboutFull TextPDF ToolsAdd to favoritesDownload...

10.1016/j.juro.2012.09.077 article EN The Journal of Urology 2012-09-24

Tolerance of the human kidney to ischemia is controversial. Here, we prospectively studied renal response clamp and reperfusion in humans, including changes putative biomarkers AKI. We performed biopsies before, during, after surgically induced 40 patients undergoing partial nephrectomy. Ischemia duration was >30 minutes 82.5% patients. There a mild, transient increase serum creatinine, but cystatin C remained stable. Renal functional did not correlate with duration. structural were much...

10.1681/asn.2012080786 article EN Journal of the American Society of Nephrology 2013-02-15

No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Jan 2003Randomized Prospective Evaluation Extended Versus Limited Lymph Node Dissection in Patients With Clinically Localized Prostate Cancer TRAVIS CLARK, DIPEN J. PAREKH, MICHAEL S. COOKSON, SAM CHANG, ERNEST R. SMITH, NANCY WELLS, and JOSEPH A. SMITH CLARKTRAVIS CLARK , PAREKHDIPEN PAREKH COOKSONMICHAEL COOKSON CHANGSAM CHANG SMITHERNEST WELLSNANCY WELLS SMITHJOSEPH View All Author...

10.1016/s0022-5347(05)64055-4 article EN The Journal of Urology 2003-01-01

// Radka Stoyanova 1 , Alan Pollack Mandeep Takhar 2 Charles Lynne 3 Nestor Parra Lucia L.C. Lam Mohammed Alshalalfa Christine Buerki Rosa Castillo 4 Merce Jorda 3, 5 Hussam Al-deen Ashab Oleksandr N. Kryvenko Sanoj Punnen Dipen J. Parekh Matthew C. Abramowitz Robert Gillies 6 Elai Davicioni Nicholas Erho Adrian Ishkanian Department of Radiation Oncology, University Miami Miller School Medicine, Miami, FL, USA Reserach and Development, GenomeDx Biosciences, Vancouver, BC, Canada Urology,...

10.18632/oncotarget.10523 article EN Oncotarget 2016-07-11

The RAZOR (Randomized Open versus Robotic Cystectomy) trial revealed noninferior 2-year progression-free survival for robotic radical cystectomy. This update was performed with extended followup 3 years to determine potential differences between the approaches. We also report 3-year overall and sought identify factors predicting recurrence, survival.We analyzed per protocol population of 302 patients from study. Cumulative recurrence estimated using nonbladder cancer death as competing risk...

10.1097/ju.0000000000000565 article EN The Journal of Urology 2019-09-24

To compare health-related quality-of-life (HRQoL) outcomes for robot-assisted laparoscopic radical cystectomy (RARC) with those of traditional open (ORC) in a prospective randomised fashion.This was clinical trial evaluating the HRQoL ORC vs RARC consecutive patients from July 2009 to June 2011. We administered Functional Assessment Cancer Therapy-Vanderbilt Cystectomy Index questionnaire, validated assess HRQoL, preoperatively and then at 3, 6, 9 12 months postoperatively. Scores each...

10.1111/bju.12818 article EN BJU International 2014-05-26

We applied nonmuscle invasive bladder cancer AUA (American Urological Association)/SUO (Society of Urologic Oncology) guidelines for risk stratification and analyzed predictors recurrence progression.We retrospectively reviewed the records 398 patients with treated between 2001 2017. Descriptive statistics were used to compare AUA/SUO groups. Predictors progression determined by multivariable regression. Kaplan-Meier analysis was done, a Cox proportional hazards regression model created time...

10.1097/ju.0000000000000593 article EN The Journal of Urology 2019-10-14

Abstract Purpose Despite the growing adoption of HIFU treatment for localized prostate cancer (PC), standardized criteria evaluating success and predicting recurrence remain undefined. Herein, we analyze predictive value noninvasive tools such as PSA dynamics MRI to determine recurrence. Methods We identified from our therapy prospective registry patients who developed biopsy-proven recurrence, between 2016 2023. Clinically significant (CS-R) was defined presence GG 2 or greater on control...

10.1007/s00345-025-05529-0 article EN cc-by World Journal of Urology 2025-03-12

We present a contemporary review of patients with renal cell carcinoma (RCC) in whom vein/inferior vena caval thrombus was treated radical nephrectomy and thrombectomy.A total 220 underwent for RCC at our institution from 1998 to 2002. Of them 49 involvement (T3b/c) were selected review. evaluated demographics, presenting symptoms, imaging modalities, clinical staging, pathological features, adjuvant treatment outcomes. also surgical incisions, liver mobilization procedures, blood loss,...

10.1097/01.ju.0000158459.42658.95 article EN The Journal of Urology 2005-05-03

No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Jan 2003Complications Radical Cystectomy For Nonmuscle Invasive Disease: Comparison With Muscle Disease MICHAEL S. COOKSON, SAM CHANG, NANCY WELLS, DIPEN J. PAREKH, and JOSEPH A. SMITH COOKSONMICHAEL COOKSON Financial interest and/or other relationship with TAP, Intracel Abbott. More articles by this author , CHANGSAM CHANG Amgen, Schering, Shire. WELLSNANCY WELLS PAREKHDIPEN PAREKH SMITHJOSEPH View All Author...

10.1016/s0022-5347(05)64045-1 article EN The Journal of Urology 2003-01-01

No AccessJournal of UrologyAdult Urology1 Oct 2008Predicting Prostate Cancer Risk Through Incorporation Gene 3is accompanied byWAVE1 is Associated With Invasiveness and Growth Cellsis corrected byErratum Donna Pauler Ankerst, Jack Groskopf, John R. Day, Amy Blase, Harry Rittenhouse, Brad H. Pollock, Cathy Tangen, Dipen Parekh, Robin J. Leach, Ian Thompson AnkerstDonna Ankerst Department Urology, University Texas Health Sciences Center, San Antonio, Epidemiology Biostatistics, , GroskopfJack...

10.1016/j.juro.2008.06.038 article EN The Journal of Urology 2008-10-01

To compare the predictive performance and potential clinical usefulness of risk calculators European Randomized Study Screening for Prostate Cancer (ERSPC RC) with without information on prostate volume.We studied 6 cohorts (5 1 US) a total 15,300 men, all biopsied pre-biopsy TRUS measurements volume. Volume was categorized into 3 categories (25, 40, 60 cc), to reflect use digital rectal examination (DRE) volume assessment. Risks cancer were calculated according ERSPC DRE-based RC (including...

10.1007/s00345-011-0804-y article EN cc-by-nc World Journal of Urology 2011-12-27

Background Inflammatory cytokines are detected in the plasma of patients with renal cell carcinoma (RCC) and associated poor prognosis. However, primary type involved producing inflammatory biological significance RCC remain unknown. Inflammation is oxidative stress, upregulation hypoxia inducible factor 1-alpha, production pro-inflammatory gene products. Solid tumors often heterogeneous oxygen tension together suggesting that may play a role processes RCC. Epithelial cells have been...

10.1371/journal.pone.0030712 article EN cc-by PLoS ONE 2012-01-27

The relationship between prostate-specific antigen (PSA) level and prostate cancer risk remains subject to fundamental disagreements. We hypothesized that the of on biopsy for a given PSA is affected by identifiable characteristics cohort under study.We used data from five European three U.S. cohorts men undergoing cancer; six were population-based studies two clinical cohorts. association was calculated separately each using locally weighted scatterplot smoothing.The final set included...

10.1158/1078-0432.ccr-10-1328 article EN Clinical Cancer Research 2010-08-25

Metastatic renal cancer manifests multiple signatures of gene expression. Deviation in expression mature miRNAs has been linked to human cancers. Importance miR-21 cell carcinomas is proposed from profiling studies using tumor tissue samples. However, the role function causing proliferation and invasion not yet shown. Using cultured carcinoma cells, we demonstrate enhanced along with pre-and pri-miR-21 by increased transcription compared normal proximal tubular epithelial cells....

10.1371/journal.pone.0037366 article EN cc-by PLoS ONE 2012-06-04
Coming Soon ...